![Andriy Mushak](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andriy Mushak
Directeur Financier/CFO chez
TELOMIR PHARMACEUTICALS, INC.
Profil
Andriy Mushak began working as Chief Financial Officer at Telomir Pharmaceuticals, Inc. in 2026 and continues in this role.
In the same year, Mr. Mushak also started as Chief Financial Officer at MIRA Pharmaceuticals, Inc. and remains in this position.
Postes actifs de Andriy Mushak
| Sociétés | Poste | Début |
|---|---|---|
| TELOMIR PHARMACEUTICALS, INC. | Directeur Financier/CFO | 06/06/2026 |
| MIRA PHARMACEUTICALS, INC. | Directeur Financier/CFO | 06/06/2026 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
1
Relations au 1er degré
2
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
MIRA Pharmaceuticals, Inc.
 MIRA Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Develops and sells new molecular synthetic THC for the treatment of adult patients with anxiety and cognitive decline | Health Technology |
Telomir Pharmaceuticals, Inc.
 Telomir Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops a novel small molecule as the first regulator of telomere length and genomic stability | Health Technology |
